HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Carlos Garcia-Porrua Selected Research
Carlos Garcia-Porrua Research Topics
Disease
9
Rheumatoid Arthritis
01/2019 - 06/2002
9
Giant Cell Arteritis (Horton Disease)
01/2006 - 08/2003
8
Purpura
01/2006 - 05/2002
5
Atherosclerosis
01/2012 - 06/2004
4
Inflammation (Inflammations)
02/2007 - 09/2005
3
Nephritis
01/2006 - 05/2002
3
Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis)
12/2003 - 03/2002
3
Cutaneous Leukocytoclastic Vasculitis (Hypersensitivity Angiitis)
10/2002 - 05/2002
2
Vasculitis (Vasculitides)
06/2006 - 05/2002
2
Disease Susceptibility (Diathesis)
12/2004 - 08/2003
2
Erythema Nodosum
02/2004 - 08/2002
2
Vascular Skin Diseases
02/2004 - 11/2002
1
Meningitis
02/2012
1
Rheumatoid Vasculitis
02/2006
1
Hypoalbuminemia
09/2005
1
Anemia
09/2005
1
Pathologic Constriction (Stenosis)
09/2005
1
Thrombocytosis (Thrombocythemia)
09/2005
1
Stroke (Strokes)
09/2005
1
Fever (Fevers)
08/2004
1
Stress Fractures (Stress Fracture)
12/2003
1
Tubulointerstitial nephritis and uveitis
10/2002
1
Leukocytosis (Pleocytosis)
10/2002
1
Uveitis
10/2002
1
Sarcoidosis (Schaumann Disease)
08/2002
1
Nephrotic Syndrome (Syndrome, Nephrotic)
07/2002
1
Renal Insufficiency (Renal Failure)
07/2002
Drug/Important Bio-Agent (IBA)
6
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2019 - 06/2004
6
HLA-DRB1 Chains (HLA DRB1)
IBA
02/2007 - 05/2002
2
Biomarkers (Surrogate Marker)
IBA
02/2007 - 09/2005
2
C-Reactive Protein
IBA
02/2007 - 07/2005
2
Steroids
IBA
06/2006 - 01/2006
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2006 - 09/2005
2
Nitric Oxide (Nitrogen Monoxide)
FDA Link
11/2005 - 06/2005
2
Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)
IBA
11/2005 - 06/2005
2
Macrophage Migration-Inhibitory Factors
IBA
01/2005 - 08/2002
2
Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)
IBA
02/2004 - 09/2003
2
Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)
IBA
02/2004 - 03/2002
2
Epitopes
IBA
06/2003 - 06/2002
1
Biological Products
IBA
01/2019
1
Calcium
IBA
02/2012
1
Adalimumab (Humira)
FDA Link
01/2012
1
Antirheumatic Agents (DMARD)
IBA
01/2012
1
Cytokines
IBA
12/2006
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
06/2006
1
Alkaline Phosphatase
IBA
09/2005
1
Hemoglobins (Hemoglobin)
IBA
09/2005
1
Phosphoprotein Phosphatases (Phosphatases, Protein)
IBA
08/2005
1
Indicators and Reagents (Reagents)
IBA
07/2005
1
Interferons
IBA
12/2004
1
Interleukin-4 (Interleukin 4)
IBA
12/2004
1
Interferon-gamma (Interferon, gamma)
IBA
12/2004
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
08/2004
1
Interleukins
IBA
02/2004
1
Interleukin-1beta (Interleukin 1 beta)
IBA
02/2004
1
Pharmaceutical Preparations
IBA
12/2003
1
Genetic Markers (Genetic Marker)
IBA
08/2003
1
HLA-DRB1*04 antigen
IBA
06/2003
1
Corticotropin-Releasing Hormone
IBA
05/2003
1
Peptides (Polypeptides)
IBA
11/2002
1
Interleukin-8 (Interleukin 8)
IBA
11/2002
1
Chemokine CCL5
IBA
11/2002
1
Orlistat (Xenical)
FDA Link
10/2002
1
Acute-Phase Proteins (Acute-Phase Protein)
IBA
10/2002
1
Interleukin-1 Receptors (Interleukin 1 Receptor)
IBA
07/2002
1
HLA Antigens (Human Leukocyte Antigens)
IBA
06/2002
1
HLA-B Antigens (HLA-B)
IBA
05/2002
1
HLA-B35 Antigen (HLA B35 Antigen)
IBA
05/2002
Therapy/Procedure
6
Therapeutics
01/2012 - 10/2002